Results 1 to 10 of about 141,326 (319)
Individualization of antiretroviral therapy
Rebecca Pavlos, Elizabeth J PhillipsInstitute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia, AustraliaAbstract: Antiretroviral therapy (ART) has evolved considerably over the last three decades.
Pavlos R, Phillips EJ
doaj +5 more sources
Initiating antiretroviral therapy
No abstract available.
Gary Maartens
doaj +5 more sources
This is Letter to the ...
Ranjan Kumar Singh
doaj +1 more source
In this article, the scientific evidence and professional guidelines regarding the timing of antiretroviral therapy initiation are reviewed, with discussion of the increasingly persuasive evidence in favor of starting treatment early in the course of human immunodeficiency virus disease.
David A. Wohl, Christopher J. Sellers
openaire +6 more sources
Hypertriglyceridemia in Antiretroviral Therapy [PDF]
Elevated serum triglycerides, total cholesterol, very low-density lipoprotein (VLDL) cholesterol, and low-density lipoprotein (LDL) cholesterol have been reported in the literature from areas where experience with antiretroviral drugs has amassed. Up until recently the use of antiretroviral drugs in Nigeria on a wide scale was a rarity owing largely to
Emmanuel Pandy Kubeyinje+1 more
openaire +4 more sources
Mental health of people living with hiv and adherence to antiretroviral therapy
Introduction Adherence to antiretroviral therapy is a key factor in predicting the success or failure of treatment. Data suggest that the status of mental health and especially depression of people living with HIV can affect adherence to antiretroviral
F. Goma+3 more
doaj +1 more source
HIV Associated Sensory Neuropathy [PDF]
Background: In the era of highly active antiretroviral therapy (HAART), sensory neuropathies have increased in prevalence. We have documented the frequency and profile of the two most common forms of sensory neuropathies associated with Human ...
Amruth G+3 more
doaj +1 more source
Antiretroviral Therapy in the Clinic [PDF]
ABSTRACT Antiretroviral therapy in the developed world has resulted in substantial reductions in HIV-associated morbidity and mortality, changing an HIV diagnosis from a likely death sentence into a manageable chronic infection (F. J. Palella, Jr., K. M. Delaney, A. C. Moorman, M. O. Loveless, J. Fuhrer, G. A. Satten, D.
Martin S. Hirsch, Athe M. N. Tsibris
openaire +3 more sources
Development and validation of a composite programmatic assessment tool for HIV therapy. [PDF]
We developed and validated a new and simple metric, the Programmatic Compliance Score (PCS), based on the IAS-USA antiretroviral therapy management guidelines for HIV-infected adults, as a predictor of all-cause mortality, at a program-wide level.
Viviane D Lima+7 more
doaj +1 more source
Background: The emergence and spread of multidrug-resistant tuberculosis (MDR-TB) presents a challenge to the ''End TB by 2035'' strategy. This study aimed to identify the risk factors associated with MDR-TB in patients admitted to the pneumo-physiology ...
Jean de Dieu Longo+6 more
doaj